NDC 49288-0488
Maple Leaf Sycamore
Maple Leaf Sycamore
Maple Leaf Sycamore is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Platanus Hybrida Pollen.
| Product ID | 49288-0488_13c9eea1-38b5-472b-b735-a814ca886718 |
| NDC | 49288-0488 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Maple Leaf Sycamore |
| Generic Name | Maple Leaf Sycamore |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1974-03-23 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102223 |
| Labeler Name | Antigen Laboratories, Inc. |
| Substance Name | PLATANUS HYBRIDA POLLEN |
| Active Ingredient Strength | 0 g/mL |
| Pharm Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |